Navigation Links
Ventas Enters Agreement to Sell Common Stock
Date:1/29/2008

states and two Canadian provinces includes seniors housing communities, skilled nursing facilities, hospitals and medical office and other properties.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding Ventas, Inc.'s ("Ventas" or the "Company") and its subsidiaries' expected future financial position, results of operations, cash flows, funds from operations, dividends and dividend plans, financing plans, business strategy, budgets, projected costs, capital expenditures, competitive positions, acquisitions, investment opportunities, merger integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust ("REIT"), plans and objectives of management for future operations and statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions are forward-looking statements. Such forward-looking statements are inherently uncertain, and security holders must recognize that actual results may differ from the Company's expectations. The Company does not undertake a duty to update such forward-looking statements, which speak only as of the date on which they are made.

The Company's actual future results and trends may differ materially depending on a variety of factors discussed in the Company's filings with the Securities and Exchange Commission. Factors that may affect the Company's plans or results include without limitation: (a) the ability and willingness of the Company's operators, tenants, borrowers, managers and other third parties, as applicable, to meet and/or perform the obligations under their various contractual arrangements with the Company; (b) the ability and willingness of Kindred Healthcare, Inc. (together with its subs
'/>"/>

SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
2. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
3. Ventas Appoints Brush SVP - Senior Housing Development and Operations
4. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
5. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
6. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
7. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
8. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. New Company Enters Companion Animal Veterinary Medicine Channel
11. Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Newswire/ -- Public interest,advocates(1) welcomed...decisions on the threats posed by mercury to human... 2nd UNEP(2) Open Ended Working Group (OEWG2) on,M... of a global framework,on mercury, in preparation ...09, where it will be decided whether a global lega...
(Date:10/10/2008)...Technology Evolution: Smarter Solutions for Better... (PRWEB) September 17, 2008 -- The New Jersey and ...e Information Management Systems Society ( HIMSS )...mation technology professionals together for a two...echnology Evolution: Smarter Solutions for Better ...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/9/2008)...e Accredited Course for,Non-Dermatologists about D...ovember 1, 2008 at the Royal Sonesta Hotel Boston,...e-USNewswire/ -- The Melanoma,Foundation of New En... are,co-sponsoring an Accreditation Council for Co...e non-dermatologists on the detection and manageme...
Breaking Medicine News(10 mins):Health News:Elements for a UN Global Framework on Mercury Agreed to 2Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2
...ked, President A.P.J. Abdul Kalam Thursday said th...ill women// who have no home. "While mental illne...themselves but also for their families, it becomes...ir families," Kalam said here at the beginning of ...
...ation of kidney diseases worldwide. According to s...are in the throes of kidney related ailments. Rep...o avoid kidney transplant is to detect the disease...s simply unaffordable for majority of the people i...
...e physicians are knowledgeable about women’s sleep...’ sleep problems. The survey issued by American Co...). It was found that most pulmonary/critical care ...erns of their female patients and are advising app...
...tt, urging the Commonwealth to convince the States...nd performance benchmarks for medical training in ... (AHCA) negotiations. The current AHCA expires i... the next agreement commence soon. AMA President...
Other Medicine News:Health News:Nearly 2,500 Mentally Ill Women in Delhi are Destitute: Abdul Kalam 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 3
(Date:10/8/2008)...(R) Element(TM) Platinum Chromium ...ewswire-FirstCall/ -- Boston Scientific,Corporatio...ted enrollment in,the PERSEUS trial, designed to e...ement(TM) paclitaxel-eluting coronary stent. The P...patients at 100 U.S. and,international centers sin...
(Date:10/7/2008)...etheus Laboratories Inc., a,specialty pharmaceutic...lopment of PROMETHEUS(R) IBS Diagnostic, the first...(IBS). The findings suggest measurable,differences...od samples,between IBS and non-IBS patients. The i... proprietary algorithm, led to the development of ...
(Date:10/7/2008)...e Osteoarthritis Research Society,International,s ...Newswire/ -- Ferring Pharmaceuticals Inc.,recently...thritis of the,Knee, showing that EUFLEXXA(R) (1% ...molecular weight form of intra-articular hyaluroni...ine (IA-saline) for the relief,of pain in knee ost...
(Date:10/7/2008)... taken once-daily significantly,improved the sympt... /- Shire plc (LSE: SHP,Na...al company, today,announced that a study published... Psychiatry found once-daily VYVANSE significantly... (ADHD) symptoms in adults within,the first week o...
Breaking Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6About one quarter of women with HIV want to become pregnant 12652 1About one quarter of women with HIV want to become pregnant 12652 2About one quarter of women with HIV want to become pregnant 12652 3About one quarter of women with HIV want to become pregnant 12652 4Danaher to Present at Citigroup Global Industrial Manufacturing Conference 12649 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 2Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 3Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 4Antibiotic Use in Dementia Patients Questioned 12644 1Antibiotic Use in Dementia Patients Questioned 12644 2Antibiotic Use in Dementia Patients Questioned 12644 3
...essed protein,protects human pancreatic cancer cel...g one of the body,s natural defenses against,out-o...ty of Texas,M. D. Anderson Cancer Center report in...he protein tissue transglutaminase, known by the a...archers at M. D. Anderson and,elsewhere to be over...
...Clinical studies have,shown (1) similar rates of n...uenza patients being treated with Tamiflu compared...za. Furthermore,recent data derived from US healt...101,000 influenza patients treated with Tamiflu,an...lu have shown,that the Tamiflu treated patients sh...
Other Medicine Technology:Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 2Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4
Duckbill. 3.5 mm tip. Light curve.
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle.
4 mm x 9 mm tip.
2 mm curved tip. Round handle. Designated most popular model or size.
Medicine Products: